Literature DB >> 3426851

Optimal dose distribution for eradication of heterogeneous tumours.

A Brahme1, A K Agren.   

Abstract

The traditional single hit multitarget theory has been applied on the probability of eradication of an organ or a tumor and the probability for causing complications in normal tissue. This simple theory predicts a decreasing possibility to achieve uncomplicated tumor control with increasing tumor size and maintained irradiation technique, because the control curve moves to higher doses and the complication curve to lower doses as the tumor size increases. This simple result is shown to be consistent with clinically observed dose response relations for small and large tumors. The optimal dose distribution for eradication of a heterogeneous tumor is derived on the assumption that a uniform minimal recurrence probability is most advantageous for the patient. The optimal dose distribution is proportional to the spatial variation of the local D0 value and the logarithm of the tumor cell density. Various techniques to measure the density of tumor cells and the different possibilities to deliver non-uniform dose distributions to the target volume are also discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3426851     DOI: 10.3109/02841868709104364

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  19 in total

1.  Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.

Authors:  R T Flynn; D L Barbee; T R Mackie; R Jeraj
Journal:  Phys Med Biol       Date:  2007-10-01       Impact factor: 3.609

Review 2.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?

Authors:  Vincent Grégoire; Robert Jeraj; John Aldo Lee; Brian O'Sullivan
Journal:  Lancet Oncol       Date:  2012-06-28       Impact factor: 41.316

Review 3.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

Review 4.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.

Authors:  Søren M Bentzen; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

5.  Feasibility of dose painting using volumetric modulated arc optimization and delivery.

Authors:  Stine S Korreman; Silke Ulrich; Steve Bowen; Michael Deveau; Søren M Bentzen; Robert Jeraj
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

6.  On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function.

Authors:  Stephen R Bowen; Ryan T Flynn; Søren M Bentzen; Robert Jeraj
Journal:  Phys Med Biol       Date:  2009-02-13       Impact factor: 3.609

7.  Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.

Authors:  Anne K Due; Ivan R Vogelius; Marianne C Aznar; Søren M Bentzen; Anne K Berthelsen; Stine S Korreman; Annika Loft; Claus A Kristensen; Lena Specht
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

8.  Failure-probability driven dose painting.

Authors:  Ivan R Vogelius; Katrin Håkansson; Anne K Due; Marianne C Aznar; Anne K Berthelsen; Claus A Kristensen; Jacob Rasmussen; Lena Specht; Søren M Bentzen
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

9.  Statistical and radiobiological analysis of the so-called thyroid stunning.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  EJNMMI Res       Date:  2015-11-19       Impact factor: 3.138

10.  Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study.

Authors:  Malene M Clausen; Anders E Hansen; Per Munck Af Rosenschold; Andreas Kjaer; Annemarie T Kristensen; Fintan J McEvoy; Svend A Engelholm
Journal:  Radiat Oncol       Date:  2013-11-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.